{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T10:18:12Z","timestamp":1767867492983,"version":"3.49.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T00:00:00Z","timestamp":1585612800000},"content-version":"am","delay-in-days":274,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.nbd.2019.03.025","type":"journal-article","created":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T03:00:41Z","timestamp":1553742041000},"page":"362-373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Upregulation of tripeptidyl-peptidase 1 by 3-hydroxy-(2,2)-dimethyl butyrate, a brain endogenous ligand of PPAR\u03b1: Implications for late-infantile Batten disease therapy"],"prefix":"10.1016","volume":"127","author":[{"given":"Sudipta","family":"Chakrabarti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujyoti","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avik","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sridevi","family":"Dasarathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhuchhanda","family":"Kundu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalipada","family":"Pahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2019.03.025_bb0005","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4049\/jimmunol.179.1.275","article-title":"Sodium benzoate, a food additive and a metabolite of cinnamon, modifies T cells at multiple steps and inhibits adoptive transfer of experimental allergic encephalomyelitis","volume":"179","author":"Brahmachari","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2019.03.025_bb0010","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1038\/sj.mt.6300249","article-title":"Timing of therapeutic intervention determines functional and survival outcomes in a mouse model of late infantile batten disease","volume":"15","author":"Cabrera-Salazar","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2019.03.025_bb0015","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/mt.2008.9","article-title":"Intraventricular enzyme replacement improves disease phenotypes in a mouse model of late infantile neuronal ceroid lipofuscinosis","volume":"16","author":"Chang","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2019.03.025_bb0020","doi-asserted-by":"crossref","unstructured":"Corbett, G. T., Roy, A., and Pahan, K. Gemfibrozil, a lipid-lowering drug, upregulates IL-1 receptor antagonist in mouse cortical neurons: implications for neuronal self-defense. J. Immunol. 189, 1002\u20131013.","DOI":"10.4049\/jimmunol.1102624"},{"key":"10.1016\/j.nbd.2019.03.025_bb0025","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1089\/hum.2004.15.1131","article-title":"Clinical protocol. Administration of a replication-deficient adeno-associated virus gene transfer vector expressing the human CLN2 cDNA to the brain of children with late infantile neuronal ceroid lipofuscinosis","volume":"15","author":"Crystal","year":"2004","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.nbd.2019.03.025_bb0030","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.4049\/jimmunol.173.2.1344","article-title":"Antineuroinflammatory effect of NF-kappaB essential modifier-binding domain peptides in the adoptive transfer model of experimental allergic encephalomyelitis","volume":"173","author":"Dasgupta","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2019.03.025_bb0035","doi-asserted-by":"crossref","first-page":"38922","DOI":"10.1074\/jbc.M112.365148","article-title":"Gemfibrozil and fenofibrate, Food and Drug Administration-approved lipid-lowering drugs, up-regulate tripeptidyl-peptidase 1 in brain cells via peroxisome proliferator-activated receptor alpha: implications for late infantile Batten disease therapy","volume":"287","author":"Ghosh","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2019.03.025_bb0040","doi-asserted-by":"crossref","first-page":"10309","DOI":"10.1074\/jbc.M114.610659","article-title":"Activation of peroxisome proliferator-activated receptor alpha induces lysosomal biogenesis in brain cells: implications for lysosomal storage disorders","volume":"290","author":"Ghosh","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2019.03.025_bb0045","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/jnc.13987","article-title":"Gemfibrozil, food and drug administration-approved lipid-lowering drug, increases longevity in mouse model of late infantile neuronal ceroid lipofuscinosis","volume":"141","author":"Ghosh","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2019.03.025_bb0055","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1523\/JNEUROSCI.06-08-02163.1986","article-title":"Characterization of ameboid microglia isolated from developing mammalian brain","volume":"6","author":"Giulian","year":"1986","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.03.025_bb0060","doi-asserted-by":"crossref","first-page":"7135","DOI":"10.1074\/jbc.M211872200","article-title":"Biosynthesis, glycosylation, and enzymatic processing in vivo of human tripeptidyl-peptidase I","volume":"278","author":"Golabek","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2019.03.025_bb0065","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s00401-005-0024-x","article-title":"Mechanisms of neurodegeneration in neuronal ceroid-lipofuscinoses","volume":"111","author":"Hachiya","year":"2006","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2019.03.025_bb0070","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1089\/hum.2005.16.1484","article-title":"Safety of direct administration of AAV2(CU)hCLN2, a candidate treatment for the central nervous system manifestations of late infantile neuronal ceroid lipofuscinosis, to the brain of rats and nonhuman primates","volume":"16","author":"Hackett","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.nbd.2019.03.025_bb0075","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s100480050032","article-title":"Chromosomal localization of two genes underlying late-infantile neuronal ceroid lipofuscinosis","volume":"1","author":"Haines","year":"1998","journal-title":"Neurogenetics"},{"key":"10.1016\/j.nbd.2019.03.025_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnen\/62.1.1","article-title":"The neuronal ceroid-lipofuscinoses","volume":"62","author":"Haltia","year":"2003","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2019.03.025_bb0085","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.bbadis.2006.06.010","article-title":"The neuronal ceroid-lipofuscinoses: from past to present","volume":"1762","author":"Haltia","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2019.03.025_bb0090","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.bbalip.2007.04.016","article-title":"PPARs in the brain","volume":"1771","author":"Heneka","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2019.03.025_bb0095","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2174\/157015911798376325","article-title":"Impact and therapeutic potential of PPARs in Alzheimer's disease","volume":"9","author":"Heneka","year":"2011","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.nbd.2019.03.025_bb0100","doi-asserted-by":"crossref","unstructured":"Khasnavis, S., Jana, A., Roy, A., Mazumder, M., Bhushan, B., Wood, T., Ghosh, S., Watson, R., and Pahan, K. Suppression of nuclear factor-kappaB activation and inflammation in microglia by physically modified saline. J. Biol. Chem. 287, 29529\u201329542.","DOI":"10.1074\/jbc.M111.338012"},{"key":"10.1016\/j.nbd.2019.03.025_bb0105","doi-asserted-by":"crossref","unstructured":"Khasnavis, S., and Pahan, K. Sodium benzoate, a metabolite of cinnamon and a food additive, upregulates neuroprotective Parkinson disease protein DJ-1 in astrocytes and neurons. J. NeuroImmune Pharmacol. 7, 424\u2013435.","DOI":"10.1007\/s11481-011-9286-3"},{"key":"10.1016\/j.nbd.2019.03.025_bb0110","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1471-4159.1996.67020677.x","article-title":"Apoptosis as the mechanism of neurodegeneration in Batten's disease","volume":"67","author":"Lane","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2019.03.025_bb0115","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1006\/geno.1998.5328","article-title":"Structural organization and sequence of CLN2, the defective gene in classical late infantile neuronal ceroid lipofuscinosis","volume":"50","author":"Liu","year":"1998","journal-title":"Genomics"},{"key":"10.1016\/j.nbd.2019.03.025_bb0120","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.bbadis.2015.05.011","article-title":"Genetics of the neuronal ceroid lipofuscinoses (Batten disease)","volume":"1852","author":"Mole","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2019.03.025_bb0125","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nprot.2006.27","article-title":"Protocol for the fast chromatin immunoprecipitation (ChIP) method","volume":"1","author":"Nelson","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.nbd.2019.03.025_bb0130","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1684\/epd.2016.0844","article-title":"Neuronal ceroid lipofuscinoses","volume":"18","author":"Nita","year":"2016","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.nbd.2019.03.025_bb0135","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.celrep.2013.07.028","article-title":"Regulation of cyclic AMP response element binding and hippocampal plasticity-related genes by peroxisome proliferator-activated receptor alpha","volume":"4","author":"Roy","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2019.03.025_bb0140","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/nchembio.2204","article-title":"Identification and characterization of PPARalpha ligands in the hippocampus","volume":"12","author":"Roy","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.nbd.2019.03.025_bb0145","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s11481-006-9020-8","article-title":"Up-regulation of BDNF in astrocytes by TNF-alpha: a case for the neuroprotective role of cytokine","volume":"1","author":"Saha","year":"2006","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.nbd.2019.03.025_bb0150","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/j.freeradbiomed.2007.03.022","article-title":"Differential regulation of Mn-superoxide dismutase in neurons and astroglia by HIV-1 gp120: implications for HIV-associated dementia","volume":"42","author":"Saha","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.nbd.2019.03.025_bb0155","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1056\/NEJMoa1712649","article-title":"Study of intraventricular cerliponase Alfa for CLN2 disease","volume":"378","author":"Schulz","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2019.03.025_bb0160","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/j.bbadis.2013.04.008","article-title":"NCL diseases \u2013 clinical perspectives","volume":"1832","author":"Schulz","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2019.03.025_bb0165","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3171\/2013.3.PEDS12397","article-title":"Central nervous system stem cell transplantation for children with neuronal ceroid lipofuscinosis","volume":"11","author":"Selden","year":"2013","journal-title":"J. Neurosurg. Pediatr"},{"key":"10.1016\/j.nbd.2019.03.025_bb0170","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1126\/science.277.5333.1802","article-title":"Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis","volume":"277","author":"Sleat","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.nbd.2019.03.025_bb0175","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ymgme.2008.01.014","article-title":"Residual levels of tripeptidyl-peptidase I activity dramatically ameliorate disease in late-infantile neuronal ceroid lipofuscinosis","volume":"94","author":"Sleat","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.nbd.2019.03.025_bb0180","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1086\/302427","article-title":"Mutational analysis of the defective protease in classic late-infantile neuronal ceroid lipofuscinosis, a neurodegenerative lysosomal storage disorder","volume":"64","author":"Sleat","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.nbd.2019.03.025_bb0185","doi-asserted-by":"crossref","first-page":"9117","DOI":"10.1523\/JNEUROSCI.2729-04.2004","article-title":"A mouse model of classical late-infantile neuronal ceroid lipofuscinosis based on targeted disruption of the CLN2 gene results in a loss of tripeptidyl-peptidase I activity and progressive neurodegeneration","volume":"24","author":"Sleat","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.03.025_bb0190","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1046\/j.1471-4159.1999.0730700.x","article-title":"Biochemical characterization of a lysosomal protease deficient in classical late infantile neuronal ceroid lipofuscinosis (LINCL) and development of an enzyme-based assay for diagnosis and exclusion of LINCL in human specimens and animal models","volume":"73","author":"Sohar","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2019.03.025_bb0195","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1001\/archneur.58.11.1793","article-title":"Feasibility of gene therapy for late neuronal ceroid lipofuscinosis","volume":"58","author":"Sondhi","year":"2001","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2019.03.025_bb0200","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/sj.mt.6300049","article-title":"Enhanced survival of the LINCL mouse following CLN2 gene transfer using the rh.10 rhesus macaque-derived adeno-associated virus vector","volume":"15","author":"Sondhi","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2019.03.025_bb0205","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.expneurol.2008.04.022","article-title":"Survival advantage of neonatal CNS gene transfer for late infantile neuronal ceroid lipofuscinosis","volume":"213","author":"Sondhi","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2019.03.025_bb0210","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1002\/1522-2683(20017)22:11<2343::AID-ELPS2343>3.0.CO;2-2","article-title":"Diagnosis of late-infantile neuronal ceroid lipofuscinosis: a new sensitive method to assay lysosomal pepstatin-insensitive proteinase activity in human and animal specimens by capillary electrophoresis","volume":"22","author":"Viglio","year":"2001","journal-title":"Electrophoresis"},{"key":"10.1016\/j.nbd.2019.03.025_bb0215","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0014-5793(98)01683-4","article-title":"Classical late infantile neuronal ceroid lipofuscinosis fibroblasts are deficient in lysosomal tripeptidyl peptidase I","volume":"443","author":"Vines","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.nbd.2019.03.025_bb0220","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ymgme.2011.06.018","article-title":"Intrathecal tripeptidyl-peptidase 1 reduces lysosomal storage in a canine model of late infantile neuronal ceroid lipofuscinosis","volume":"104","author":"Vuillemenot","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.nbd.2019.03.025_bb0225","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/humu.21251","article-title":"Functional consequences and rescue potential of pathogenic missense mutations in tripeptidyl peptidase I","volume":"31","author":"Walus","year":"2010","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.nbd.2019.03.025_bb0230","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/j.bbadis.2013.03.017","article-title":"Genetic basis and phenotypic correlations of the neuronal ceroid lipofusinoses","volume":"1832","author":"Warrier","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2019.03.025_bb0235","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1212\/WNL.0b013e31825f0547","article-title":"New nomenclature and classification scheme for the neuronal ceroid lipofuscinoses","volume":"79","author":"Williams","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2019.03.025_bb0240","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1089\/hum.2008.022","article-title":"Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA","volume":"19","author":"Worgall","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.nbd.2019.03.025_bb0245","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1038\/mt.2011.130","article-title":"Large-volume intrathecal enzyme delivery increases survival of a mouse model of late infantile neuronal ceroid lipofuscinosis","volume":"19","author":"Xu","year":"2011","journal-title":"Mol. Ther."}],"updated-by":[{"DOI":"10.1016\/j.nbd.2024.106479","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000}}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996119300786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996119300786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:18:19Z","timestamp":1760851099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996119300786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":48,"alternative-id":["S0969996119300786"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2019.03.025","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Upregulation of tripeptidyl-peptidase 1 by 3-hydroxy-(2,2)-dimethyl butyrate, a brain endogenous ligand of PPAR\u03b1: Implications for late-infantile Batten disease therapy","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2019.03.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}